CSIMarket


National Research Corporation  (NASDAQ: NRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

National Research Corporation

NRC's Fundamental analysis








National Research's sales fell by -5.6 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1358

Medical Laboratories industry recorded growth of revenues by 6.58 %

National Research's net profit decreased by -27.78 % in III. Quarter 2024 year on year, to $6 millions.

More on NRC's Growth


National Research
current PE on trailing twelve month basis is above Medical Laboratories industry average.

National Research realized cash reduction of $ -0.02 per share in trailing twelve-month period.
Company
14.74
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.75.
Medical Laboratories industry's Price to Sales ratio is at 2.54.


More on NRC's Valuation
 
 Total Debt (Millions $) 49
 Dividend TTM ($) 0.48 $
 Dividend Yield TTM (%) 2.88 %
 Revenue/Employee (TTM) $ 240,257
 Net Income/Employee (TTM) $ 45,133
 Receivable Turnover (TTM) 12.92
 Tangible Book Value (Per Share $) -1.44

National Research
current PE on trailing twelve month basis is above Medical Laboratories industry average.

National Research realized cash outflow of $ -0.02per share in trailing twelve-month period.
Company
14.74
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.75.
Medical Laboratories industry's Price to Sales ratio is at 2.54.

National Research Price to Book Ratio is at 11.45 lower than Industry Avg. of 29.03. and higher than S&P 500 Avg. of 0.02

More on NRC's Valuation

  Market Capitalization (Millions $) 396
  Shares Outstanding (Millions) 24
  Employees 600
  Revenues (TTM) (Millions $) 144
  Net Income (TTM) (Millions $) 27
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -15
  Total Debt (Millions $) 49
  Dividend TTM ($) 0.48 $
  Dividend Yield TTM (%) 2.88 %
  Revenue/Employee (TTM) $ 240,257
  Net Income/Employee(TTM) $ 45,133
  Receivable Turnover Ratio (TTM) 12.92
  Tangible Book Value (Per Share $) -1.44

  Market Capitalization (Millions $) 396
  Shares Outstanding (Millions) 24
  Employees 600
  Revenues (TTM) (Millions $) 144
  Net Income (TTM) (Millions $) 27
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -15


    NRC's Profitability Comparisons
National Research faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 22.28 % from 25.31 % in II. Quarter.

National Research net profit margin of 15.88 % is currently ranking no. 2 in Medical Laboratories industry, ranking no. 71 in Healthcare sector and number 914 in S&P 500.


Profitability by Segment
Total 15.88 %



  Ratio
   Capital Ratio (MRQ) 0.47
  Total Debt to Equity (MRQ) 1.4
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 1.17
  Inventory Turnover Ratio (TTM) -



National Research faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 22.28 % from 25.31 % in II. Quarter.

National Research net profit margin of 15.88 % is currently ranking no. 2 in Medical Laboratories industry, ranking no. 71 in Healthcare sector and number 914 in S&P 500.

More on NRC's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com